The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients

The superior effect of bezlotoxumab 10 mg/kg in the prevention of recurrent C. difficile infection suggests that the agent will be useful in the rapidly aging Japanese society.